132 related articles for article (PubMed ID: 11711779)
1. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?
Farinati F; Gianni S; Marin G; Fagiuoli S; Rinaldi M; Naccarato R
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1217-24. PubMed ID: 11711779
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
4. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.
Savastano S; Miotto D; Casarrubea G; Teso S; Chiesura-Corona M; Feltrin GP
J Clin Gastroenterol; 1999 Jun; 28(4):334-40. PubMed ID: 10372931
[TBL] [Abstract][Full Text] [Related]
8. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
[TBL] [Abstract][Full Text] [Related]
9. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.
Livraghi T; Bolondi L; Buscarini L; Cottone M; Mazziotti A; Morabito A; Torzilli G
J Hepatol; 1995 May; 22(5):522-6. PubMed ID: 7650331
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
[TBL] [Abstract][Full Text] [Related]
12. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.
Farinati F; De Maria N; Marafin C; Herszènyi L; Del Prato S; Rinaldi M; Perini L; Cardin R; Naccarato R
Dig Dis Sci; 1996 Dec; 41(12):2332-9. PubMed ID: 9011438
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.
Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Mar; 37(3):350-5. PubMed ID: 11916199
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatocellular carcinoma using transarterial chemoembolization: a real-life, single-centre study from Southern Brazil.
Lionço LC; de Mattos AA; Horbe AF; Costabeber AM; de Mattos ÂZ; Tarasconi DP
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):225-230. PubMed ID: 27759574
[TBL] [Abstract][Full Text] [Related]
15. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
16. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
17. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas.
Saccheri S; Lovaria A; Sangiovanni A; Nicolini A; De Fazio C; Ronchi G; Fasani P; Del Ninno E; Colombo M
J Vasc Interv Radiol; 2002 Oct; 13(10):995-9. PubMed ID: 12397120
[TBL] [Abstract][Full Text] [Related]
18. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization.
Colella G; Bottelli R; De Carlis L; Sansalone CV; Rondinara GF; Alberti A; Belli LS; Gelosa F; Iamoni GM; Rampoldi A; De Gasperi A; Corti A; Mazza E; Aseni P; Meroni A; Slim AO; Finzi M; Di Benedetto F; Manochehri F; Follini ML; Ideo G; Forti D
Transpl Int; 1998; 11 Suppl 1():S193-6. PubMed ID: 9664977
[TBL] [Abstract][Full Text] [Related]
20. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
